Resection of glioma: best clinics abroad

Glioma is a group of tumours arising from cells associated with the brain's supporting tissue. These tumours differ in their growth pattern, grade and molecular characteristics. Surgery may provide a diagnosis, reduce tumour volume, relieve pressure or help control symptoms. The aim is to remove tissue safely while protecting movement, language, memory and other functions. A diffuse glioma may extend beyond its visible boundaries, limiting complete removal.

A decision about surgery combines MRI findings, symptoms, changes over time and general health. Some situations call for biopsy, while selected lower-risk tumours may be monitored after specialist review. Further radiotherapy or medicines depend on the final diagnosis rather than the word “glioma” alone. Patients may seek care abroad for a second opinion, specialist mapping or review of pathology. Before travelling, clarify the proposed surgical goal, neurological risks, rehabilitation needs and how results and follow-up will be shared with the team at home.

Understanding the tumour before choosing surgery

Gliomas include several biologically different tumours. MRI shows location and extent, but tissue examination and molecular testing can refine the diagnosis and guide treatment. The team reviews seizures, neurological changes and earlier scans. A lower grade does not mean that follow-up is unnecessary, and a rapidly changing tumour may need a different approach. The decision belongs within specialist neurosurgical care.

Resection, biopsy or monitoring

Resection seeks to remove as much tumour as possible without unacceptable loss of function. When the tumour involves critical structures, a smaller resection or image-guided biopsy may be appropriate. Active monitoring is an option in selected situations after multidisciplinary assessment, with a defined review plan. It is not simply leaving the finding unchecked. Ask what would trigger a change in management and which uncertainties remain.

Preparing for a functional approach

Provide original imaging, reports, any tissue samples available for review and a full treatment history. Baseline testing may assess speech, movement or cognition. The anaesthetic team reviews health and medicines and provides instructions about fasting and any medication changes. If awake mapping is proposed, the team explains the tasks, communication needs and suitability; it is not necessary for every patient.

Operation and early recovery

Through a skull opening, the surgeon accesses the tumour and removes tissue within the agreed limits. Navigation, mapping, monitoring or intraoperative imaging may support decisions when appropriate. The bone opening and wound are then closed. Afterwards, staff assess neurological function and arrange imaging and pathology review. Remaining tumour may reflect a deliberate decision to protect function.

Risks include bleeding, infection, brain swelling, seizures and temporary or permanent changes in strength, speech, vision or thinking. Serious complications can be life-threatening. Rehabilitation may help with daily tasks and communication. New weakness, reduced consciousness, a prolonged seizure or rapidly worsening symptoms require urgent assessment; wound problems need prompt contact.

Results, follow-up and costs

The final subtype, grade, molecular findings and residual tumour determine whether observation, radiotherapy or medicines are recommended. Follow-up combines scans with review of physical, cognitive and emotional wellbeing. Costs depend on investigations, mapping, surgery, hospital care and rehabilitation. Agree safe travel and responsibility for ongoing treatment before returning home.

Frequently asked questions

Are all gliomas glioblastomas?

No. Glioblastoma is one type; other gliomas can behave differently.

Must every glioma be removed completely?

No. The safest useful extent depends on anatomy and tumour characteristics.

Will surgery be the only treatment?

Sometimes, but other tumours require additional therapy and continued surveillance.